Corporate ActionJun 8, 2026, 08:02 AM
BioCardia raises $4.4M via ATM offering, extends cash runway
AI Summary
BioCardia, Inc. announced it raised approximately $4.4 million through an "At The Market" (ATM) offering. The company sold 3,509,604 shares at an average price of $1.279 per share on June 5, 2026. These net proceeds are expected to extend BioCardia's cash runway into the first quarter of 2027, covering operations beyond the anticipated Japan PMDA submission for CardiAMP HF in Q4 2026. Further exercise of outstanding warrants could extend the runway even further, potentially into first commercial sales.
Key Highlights
- BioCardia raised approximately $4.4 million in gross proceeds.
- The company sold 3,509,604 shares through an "At The Market" offering.
- Shares were sold at an average price of $1.279 each on June 5, 2026.
- The financing is expected to extend the cash runway into Q1 2027.
- This covers operations beyond the anticipated Japan PMDA submission for CardiAMP HF in Q4 2026.
- No warrants were issued in this capital raise.
Price Impact
More from BCDA